microbial symbiosis factor prevents intestinal inflammatory disease 
humans colonized multitudes commensal organisms representing members five six kingdoms life however gastrointestinal tract provides residence beneficial potentially pathogenic microorganisms imbalances composition bacterial microbiota known dysbiosis postulated major factor human disorders inflammatory bowel disease report prominent human symbiont bacteroides fragilis protects animals experimental colitis induced helicobacter hepaticus commensal bacterium pathogenic potential beneficial activity requires single microbial molecule polysaccharide psa animals harbouring b fragilis expressing psa h hepaticus colonization leads disease pro inflammatory cytokine production colonic tissues purified psa administered animals required suppress pro inflammatory interleukin production intestinal immune cells also inhibits vitro reactions cell cultures furthermore psa protects inflammatory disease functional requirement interleukin producing cd4+ t cells results show molecules bacterial microbiota can mediate critical balance health disease harnessing immunomodulatory capacity symbiosis factors psa might potentially provide therapeutics human inflammatory disorders basis entirely novel biological principles 
